387 related articles for article (PubMed ID: 28454559)
1. Dose tracking assessment for image-guided radiotherapy of the prostate bed and the impact on clinical workflow.
Orlandini LC; Coppola M; Fulcheri C; Cernusco L; Wang P; Cionini L
Radiat Oncol; 2017 Apr; 12(1):78. PubMed ID: 28454559
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of online/offline image guidance/adaptation approaches for prostate cancer radiation therapy.
Qin A; Sun Y; Liang J; Yan D
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1026-33. PubMed ID: 25832693
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric and radiobiological consequences of computed tomography-guided adaptive strategies for intensity modulated radiation therapy of the prostate.
Battista JJ; Johnson C; Turnbull D; Kempe J; Bzdusek K; Van Dyk J; Bauman G
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):874-80. PubMed ID: 23978708
[TBL] [Abstract][Full Text] [Related]
4. Assessment and management of interfractional variations in daily diagnostic-quality-CT guided prostate-bed irradiation after prostatectomy.
Liu F; Ahunbay E; Lawton C; Li XA
Med Phys; 2014 Mar; 41(3):031710. PubMed ID: 24593714
[TBL] [Abstract][Full Text] [Related]
5. Influence of daily imaging on plan quality and normal tissue toxicity for prostate cancer radiotherapy.
Bell K; Heitfeld M; Licht N; Rübe C; Dzierma Y
Radiat Oncol; 2017 Jan; 12(1):7. PubMed ID: 28069053
[TBL] [Abstract][Full Text] [Related]
6. Associations between volume changes and spatial dose metrics for the urinary bladder during local versus pelvic irradiation for prostate cancer.
Casares-Magaz O; Moiseenko V; Hopper A; Pettersson NJ; Thor M; Knopp R; Deasy JO; Muren LP; Einck J
Acta Oncol; 2017 Jun; 56(6):884-890. PubMed ID: 28401808
[TBL] [Abstract][Full Text] [Related]
7. Retrospective study comparing MR-guided radiation therapy (MRgRT) setup strategies for prostate treatment: repositioning vs. replanning.
Kim JI; Park JM; Choi CH; An HJ; Kim YJ; Kim JH
Radiat Oncol; 2019 Aug; 14(1):139. PubMed ID: 31387593
[TBL] [Abstract][Full Text] [Related]
8. Is Dose Deformation-Invariance Hypothesis Verified in Prostate IGRT?
Simon A; Le Maitre A; Nassef M; Rigaud B; Castelli J; Acosta O; Haigron P; Lafond C; de Crevoisier R
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(4):830-838. PubMed ID: 28244420
[TBL] [Abstract][Full Text] [Related]
9. Application of aSi-kVCBCT for Volume Assessment and Dose Estimation: An Offline Adaptive Study for Prostate Radiotherapy.
Gandhi A; Vellaiyan S; Subramanian S; Swamy ST; Subramanian K; Ayyalusamy A
Asian Pac J Cancer Prev; 2019 Jan; 20(1):229-234. PubMed ID: 30678437
[TBL] [Abstract][Full Text] [Related]
10. Practical method of adaptive radiotherapy for prostate cancer using real-time electromagnetic tracking.
Olsen JR; Noel CE; Baker K; Santanam L; Michalski JM; Parikh PJ
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1903-11. PubMed ID: 21470786
[TBL] [Abstract][Full Text] [Related]
11. Cone beam CT-based dose accumulation and analysis of delivered dose to the dominant intraprostatic lesion in primary radiotherapy of prostate cancer.
Tamihardja J; Cirsi S; Kessler P; Razinskas G; Exner F; Richter A; Polat B; Flentje M
Radiat Oncol; 2021 Oct; 16(1):205. PubMed ID: 34702305
[TBL] [Abstract][Full Text] [Related]
12. A feature alignment score for online cone-beam CT-based image-guided radiotherapy for prostate cancer.
Hargrave C; Deegan T; Poulsen M; Bednarz T; Harden F; Mengersen K
Med Phys; 2018 Jul; 45(7):2898-2911. PubMed ID: 29772077
[TBL] [Abstract][Full Text] [Related]
13. Relationship between pelvic organ-at-risk dose and clinical target volume in postprostatectomy patients receiving intensity-modulated radiotherapy.
Stanic S; Mathai M; Cui J; Purdy JA; Valicenti RK
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1897-902. PubMed ID: 21536391
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric and volumetric changes in the rectum and bladder in patients receiving CBCT-guided prostate IMRT: analysis based on daily CBCT dose calculation.
Pearson D; Gill SK; Campbell N; Reddy K
J Appl Clin Med Phys; 2016 Nov; 17(6):107-117. PubMed ID: 27929486
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric effects of adaptive prostate cancer radiotherapy in an MR-linac workflow.
Mannerberg A; Persson E; Jonsson J; Gustafsson CJ; Gunnlaugsson A; Olsson LE; Ceberg S
Radiat Oncol; 2020 Jul; 15(1):168. PubMed ID: 32650811
[TBL] [Abstract][Full Text] [Related]
16. Optimization of treatment planning workflow and tumor coverage during daily adaptive magnetic resonance image guided radiation therapy (MR-IGRT) of pancreatic cancer.
Olberg S; Green O; Cai B; Yang D; Rodriguez V; Zhang H; Kim JS; Parikh PJ; Mutic S; Park JC
Radiat Oncol; 2018 Mar; 13(1):51. PubMed ID: 29573744
[TBL] [Abstract][Full Text] [Related]
17. Image-guided intensity-modulated radiotherapy of prostate cancer: Analysis of interfractional errors and acute toxicity.
Rudat V; Nour A; Hammoud M; Alaradi A; Mohammed A
Strahlenther Onkol; 2016 Feb; 192(2):109-17. PubMed ID: 26545764
[TBL] [Abstract][Full Text] [Related]
18. Megavoltage cone beam computed tomography dose and the necessity of reoptimization for imaging dose-integrated intensity-modulated radiotherapy for prostate cancer.
Akino Y; Koizumi M; Sumida I; Takahashi Y; Ogata T; Ota S; Isohashi F; Konishi K; Yoshioka Y
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1715-22. PubMed ID: 21620584
[TBL] [Abstract][Full Text] [Related]
19. Testicular doses in image-guided radiotherapy of prostate cancer.
Deng J; Chen Z; Yu JB; Roberts KB; Peschel RE; Nath R
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e39-47. PubMed ID: 21489702
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance only workflow and validation of dose calculations for radiotherapy of prostate cancer.
Christiansen RL; Jensen HR; Brink C
Acta Oncol; 2017 Jun; 56(6):787-791. PubMed ID: 28464739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
